▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #502 by analyst upside · 2026-11-07
INKT
MiNK Therapeutics, Inc.
Healthcare · Market Cap $53M · P/E 0x
ANALYST PRICE TARGET
+310.6%
implied upside to consensus target
Current Price $10.35
Consensus Target $42.5
Bull Target $50.0
Bear Target $35.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $8.48
52-Week High $16.93
YTD Return -6.9%
FUNDAMENTALS
Market Cap $53M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.39
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $8.48
52-Week High $16.93
Current Price $10.35
Bear Target $35.0
Bull Target $50.0
● Now $10.35 ● Target $42.5
TRADING DATA
Avg Volume 14K
YTD Return -6.9%
Analyst Count 2
Consensus Buy
Upside to Target +310.6%
Last Updated 2026-11-07

ANALYST SUMMARY

MiNK Therapeutics, Inc. (INKT) is currently trading at $10.35 with a Wall Street consensus price target of $42.5, implying potential upside of 310.6% over the next 12 months. 2 analysts currently cover INKT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $50.0, while the most cautious has a target of $35.0.

INKT operates in the Healthcare sector with a market capitalisation of $53M. The stock is down 6.9% year-to-date and is currently trading near the lower end of its 52-week range of $8.48 – $16.93.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for INKT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B. Riley Securities reit
Buy → Buy 2026-10-21 17% win rate (6 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-05-18 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-04-01 31% win rate (48 calls)
HC Wainwright & Co. ↑ Upgrade
Neutral → Buy 2025-08-15 31% win rate (48 calls)
HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2025-07-15 31% win rate (48 calls)
William Blair ↓ Downgrade
Outperform → Market Perform 2025-07-14 44% win rate (9 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-18 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-02-25 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
36
out of 100
Coverage depth
8/30
Consensus clarity
1/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →